Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 911-920 of 10604

Edit search filters
  1. Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

    Scottsdale/Phoenix, AZ

  2. Gout: Allopurinol vs. Febuxostat

    Rochester, MN

  3. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

  4. The Relationship Between Age and Carpal Tunnel Size

    Jacksonville, FL

  5. A Study of MR-Guided Laser Ablation of Prostate Bed Recurrences

    Rochester, MN

  6. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Evaluating Adult Patient Temperatures During Lower Spinal Surgery

    Rochester, MN

  8. A Study of the Effect of Colesevelam on Glucose Metabolism in Patients with Type 2 Diabetes

    Rochester, MN

  9. Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

    Scottsdale/Phoenix, AZ

  10. Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS

    Jacksonville, FL

.

Mayo Clinic Footer